Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma
When diagnosing endometrial carcinoma cases, we encountered histological features that strikingly resembled uterine mesonephric-like adenocarcinoma (MLA), but the differential diagnosis remained challenging after performing immunostaining. Considering the aggressive biological behavior and poor prog...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/8/1450 |
_version_ | 1797524187123810304 |
---|---|
author | Sujin Park Go Eun Bae Jiyoung Kim Hyun-Soo Kim |
author_facet | Sujin Park Go Eun Bae Jiyoung Kim Hyun-Soo Kim |
author_sort | Sujin Park |
collection | DOAJ |
description | When diagnosing endometrial carcinoma cases, we encountered histological features that strikingly resembled uterine mesonephric-like adenocarcinoma (MLA), but the differential diagnosis remained challenging after performing immunostaining. Considering the aggressive biological behavior and poor prognosis of uterine MLA, we believe that the accurate recognition of mesonephric-like differentiation (MLD) is important in the diagnosis of endometrial carcinoma. We aimed to investigate the clinicopathological and molecular characteristics of such cases and compared them with those of uterine MLAs. Five patients diagnosed with endometrioid carcinoma (EC) with MLD were included in this study. Histological evaluation, immunostaining, and targeted sequencing were performed. All five tumors showed typical morphological features of MLA, including densely aggregated tubular structures, deep basophilia under low-power magnification microscopy, eosinophilic intraluminal secretions, and diverse growth patterns. Immunostaining revealed moderate-to-strong nuclear immunoreactivity for estrogen and progesterone receptors in more than 50% tumor cells. The staining intensities and proportions of PAX2 and GATA3 were variable. None of the tumors harbored <i>KRAS</i> mutations. Considering the prognostic implications, ancillary tests, including immunostaining and targeted sequencing, should be performed to accurately differentiate between endometrial EC-MLD and uterine MLA. |
first_indexed | 2024-03-10T08:53:49Z |
format | Article |
id | doaj.art-9d9b62aaf1bf4aa4a1e211f696903eb0 |
institution | Directory Open Access Journal |
issn | 2075-4418 |
language | English |
last_indexed | 2024-03-10T08:53:49Z |
publishDate | 2021-08-01 |
publisher | MDPI AG |
record_format | Article |
series | Diagnostics |
spelling | doaj.art-9d9b62aaf1bf4aa4a1e211f696903eb02023-11-22T07:20:40ZengMDPI AGDiagnostics2075-44182021-08-01118145010.3390/diagnostics11081450Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like AdenocarcinomaSujin Park0Go Eun Bae1Jiyoung Kim2Hyun-Soo Kim3Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Pathology, Chungnam National University School of Medicine, Daejeon 34134, KoreaDepartment of Pathology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon 21431, KoreaDepartment of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaWhen diagnosing endometrial carcinoma cases, we encountered histological features that strikingly resembled uterine mesonephric-like adenocarcinoma (MLA), but the differential diagnosis remained challenging after performing immunostaining. Considering the aggressive biological behavior and poor prognosis of uterine MLA, we believe that the accurate recognition of mesonephric-like differentiation (MLD) is important in the diagnosis of endometrial carcinoma. We aimed to investigate the clinicopathological and molecular characteristics of such cases and compared them with those of uterine MLAs. Five patients diagnosed with endometrioid carcinoma (EC) with MLD were included in this study. Histological evaluation, immunostaining, and targeted sequencing were performed. All five tumors showed typical morphological features of MLA, including densely aggregated tubular structures, deep basophilia under low-power magnification microscopy, eosinophilic intraluminal secretions, and diverse growth patterns. Immunostaining revealed moderate-to-strong nuclear immunoreactivity for estrogen and progesterone receptors in more than 50% tumor cells. The staining intensities and proportions of PAX2 and GATA3 were variable. None of the tumors harbored <i>KRAS</i> mutations. Considering the prognostic implications, ancillary tests, including immunostaining and targeted sequencing, should be performed to accurately differentiate between endometrial EC-MLD and uterine MLA.https://www.mdpi.com/2075-4418/11/8/1450endometriumendometrial cancerendometrioid carcinomauterusmesonephric-like adenocarcinomaimmunohistochemistry |
spellingShingle | Sujin Park Go Eun Bae Jiyoung Kim Hyun-Soo Kim Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma Diagnostics endometrium endometrial cancer endometrioid carcinoma uterus mesonephric-like adenocarcinoma immunohistochemistry |
title | Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma |
title_full | Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma |
title_fullStr | Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma |
title_full_unstemmed | Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma |
title_short | Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma |
title_sort | mesonephric like differentiation of endometrial endometrioid carcinoma clinicopathological and molecular characteristics distinct from those of uterine mesonephric like adenocarcinoma |
topic | endometrium endometrial cancer endometrioid carcinoma uterus mesonephric-like adenocarcinoma immunohistochemistry |
url | https://www.mdpi.com/2075-4418/11/8/1450 |
work_keys_str_mv | AT sujinpark mesonephriclikedifferentiationofendometrialendometrioidcarcinomaclinicopathologicalandmolecularcharacteristicsdistinctfromthoseofuterinemesonephriclikeadenocarcinoma AT goeunbae mesonephriclikedifferentiationofendometrialendometrioidcarcinomaclinicopathologicalandmolecularcharacteristicsdistinctfromthoseofuterinemesonephriclikeadenocarcinoma AT jiyoungkim mesonephriclikedifferentiationofendometrialendometrioidcarcinomaclinicopathologicalandmolecularcharacteristicsdistinctfromthoseofuterinemesonephriclikeadenocarcinoma AT hyunsookim mesonephriclikedifferentiationofendometrialendometrioidcarcinomaclinicopathologicalandmolecularcharacteristicsdistinctfromthoseofuterinemesonephriclikeadenocarcinoma |